Surface-active derivative of inulin (Inutec® SP1) is a superior carrier for solid dispersions with a high drug load

Journal of Pharmaceutical Sciences

Volumn 100, Issue 6, 2011, Pages 2333-2342

  Srinarong, Parinda ^a   Hämäläinen, Suvi ^b   Visser, Marinella R ^a   Hinrichs, Wouter L J ^a   Ketolainen, Jarkko ^b   Frijlink, Henderik W ^a  

^a UNIVERSITY OF GRONINGEN   (Netherlands)

^b UNIVERSITY OF EASTERN FINLAND   (Finland)

Author keywords

Amorphous; Dissolution; Inulin; Inulin derivative; Inutec SP1; Polyvinylpyrrolidone; Preformulation; Solid dispersion; Spray freeze drying; Surfactants

Indexed keywords

DIAZEPAM; DRUG CARRIER; EFAVIRENZ; FENOFIBRATE; INULIN; INULIN DERIVATIVE; INUTEC SP1; POVIDONE; RITONAVIR; SURFACTANT; UNCLASSIFIED DRUG;

ARTICLE; DIFFERENTIAL SCANNING CALORIMETRY; DISPERSION; DRUG SOLUBILITY; DRUG STABILITY; DRUG STORAGE; FREEZE DRYING; GLASS TRANSITION TEMPERATURE; PREFORMULATION; SCANNING ELECTRON MICROSCOPY; SURFACE PROPERTY; SURFACE TENSION;

EID: 79954585108     PISSN: 00223549     EISSN: 15206017     Source Type: Journal    
DOI: 10.1002/jps.22471     Document Type: Article

References (28)

1. Kerc J, Srcic S, Knez Z, Sencar-Bozic P. 1999. Micronization of drugs using supercritical carbon dioxide. Int J Pharm 182:33-39.
2. Marengo E, Cavalli R, Rovero G, Gasco MR. 2003. Scale-up and optimization of an evaporative drying process applied to aqueous dispersions of solid lipid nanoparticles. Pharm Dev Technol 8:299-309.
3. Newa M, Bhandari KH, Oh DH, Kim YR, Sung JH, Kim JO, Woo JS, Choi HG, Yong CS. 2008. Enhanced dissolution of ibuprofen using solid dispersion with poloxamer 407. Arch Pharm Res 31:1497-1507.
4. Dahlberg C, Millqvist-Fureby A, Schuleit M. 2008. Surface composition and contact angle relationships for differently prepared solid dispersions. Eur J Pharm Biopharm 70:478-485.
5. Laitinen R, Suihko E, Toukola K, Björkqvist M, Riikonen J, Lehto VP, Järvinen K, Ketolainen J. 2009. Intraorally fast-dissolving particles of a poorly soluble drug: Preparation and in vitro characterization. Eur J Pharm Biopharm 71:271-281.
6. Srinarong P, Faber JH, Visser MR, Hinrichs WLJ, Frijlink HW. 2009. Strongly enhanced dissolution rate of fenofibrate solid dispersion tablets by incorporation of superdisintegrants. Eur J Pharm Biopharm 73:154-161.
7. Ghebremeskel AN, Vemavarapu C, Lodaya M. 2006. Use of surfactants as plasticizers in preparing solid dispersions of poorly soluble API: Stability testing of selected solid dispersions. Pharm Res 23:1928-1936.
8. de Waard H, Hinrichs WLJ, Visser MR, Bologna C, Frijlink HW. 2008. Unexpected differences in dissolution behavior of tablets prepared from solid dispersions with a surfactant physically mixed or incorporated. Int J Pharm 349:66-73.
9. van Drooge DJ, Hinrichs WLJ, Frijlink HW. 2004. Anomalous dissolution behaviour of tablets prepared from sugar glass-based solid dispersions. J Control Release 97:441-452.
10. Tadros TF, Vandamme A, Levecke B, Booten K, Stevens CV. 2004. Stabilization of emulsions using polymeric surfactants based on inulin. Adv Colloid Interface Sci 108-109:207-226.
11. Van Den Mooter G, Weuts I, De Ridder T, Blaton N. 2006. Evaluation of Inutec SP1 as a new carrier in the formulation of solid dispersions for poorly soluble drugs. Int J Pharm 316:1-6.
12. Gupta P, Thilagavathi R, Chakraborti AK, Bansal AK. 2005. Role of molecular interaction in stability of celecoxib-PVP amorphous systems. Mol Pharm 2:384-391.
13. Karavas E, Ktistis G, Xenakis A, Georgarakis E. 2005. Miscibility behavior and formation mechanism of stabilized felodipine-polyvinylpyrrolidone amorphous solid dispersions. Drug Dev Ind Pharm 31:473-489.
14. Fakes MG, Vakkalagadda BJ, Qian F, Desikan S, Gandhi RB, Lai C, Hsieh A, Franchini MK, Toale H, Brown J. 2009. Enhancement of oral bioavailability of an HIV-attachment inhibitor by nanosizing and amorphous formulation approaches. Int J Pharm 370:167-174.
15. US Pharmacopeia 29. 2006. General official monograph/diazepam. Rockville, Maryland: US Pharmacopeial Convention; pp 673-674.
16. Granero GE, Ramachandran C, Amidon GL. 2005. Dissolution and solubility behavior of fenofibrate in sodium lauryl sulfate solutions. Drug Dev Ind Pharm 31:917-922.
17. Gadkari T, Chandrachood P, Ruikar A, Tele S, Deshpande D, Salvekar J, Sonawane S. 2010. Validated stability indicating LC-PDA-MS method to investigate pH rate profile and degradation kinetics of efavirenz and identification of hydrolysis product by LCMS. Int J Pharm Pharm Sci 2:169-176.
18. Donato E, Dias C, Rossi R, Valente R, Fröehlich P, Bergold A. 2006. LC method for studies on the stability of lopinavir and ritonavir in soft gelatin capsules. Chromatographia 63:437-443.
19. van Drooge DJ, Hinrichs WLJ, Frijlink HW. 2004. Incorporation of lipophilic drugs in sugar glasses by lyophilization using a mixture of water and tertiary butyl alcohol as solvent. J Pharm Sci 93:713-725.
20. Rabel SR, Maurin MB, Rowe SM, Hussain M. 1996. Determination of the pKa and pH-solubility behavior of an ionizable cyclic carbamate, (S)-6-chloro-4-(cyclopropylethynyl)-1, 4-dihydro-4- (trifluoromethyl)-2H-3, 1-benzoxazin-2-one (DMP 266). Pharm Dev Technol 1:91-95.
21. Mithani SD, Bakatselou V, TenHoor CN, Dressman JB. 1996. Estimation of the increase in solubility of drugs as a function of bile salt concentration. Pharm Res 13:163-167.
22. Law D, Krill SL, Schmitt EA, Fort JJ, Qiu Y, Wang W, Porter WR. 2001. Physicochemical considerations in the preparation of amorphous ritonavir-poly(ethylene glycol) 8000 solid dispersions. J Pharm Sci 90:1015-1025.
23. Takano R, Sugano K, Higashida A, Hayashi Y, Machida M, Aso Y, Yamashita S. 2006. Oral absorption of poorly water-soluble drugs: Computer simulation of fraction absorbed in humans from a miniscale dissolution test. Pharm Res 23:1144-1156.
24. Vogt M, Kunath K, Dressman JB. 2008. Dissolution enhancement of fenofibrate by micronization, cogrinding and spray-drying: Comparison with commercial preparations. Eur J Pharm Biopharm 68:283-288.
25. Black S, Muller F. 2010. On the effect of temperature on aqueous solubility of organic solids. Org Process Res Dev 14:661-665.
26. Patel AR, Vavia PR. 2006. Effect of hydrophilic polymer on solubilization of fenofibrate by cyclodextrin complexation. J Incl Phenom Macrocycl Chem 56:247-251.
27. van Drooge DJ, Hinrichs WLJ, Visser MR, Frijlink HW. 2006. Characterization of the molecular distribution of drugs in glassy solid dispersions at the nano-meter scale, using differential scanning calorimetry and gravimetric water vapour sorption techniques. Int J Pharm 310:220-229.
28. Crowley KJ, Zografi G. 2002. Water vapor absorption into amorphous hydrophobic drug/poly(vinylpyrrolidone) dispersions. J Pharm Sci 91:2150-2165.